MedPageToday -- The use of tumor necrosis factor (TNF)-alpha blockers in children may increase the risk of malignancy, particularly when these drugs are given for inflammatory bowel disease rather than for rheumatic conditions, a study found.
MedPageToday -- The use of tumor necrosis factor (TNF)-alpha blockers in children may increase the risk of malignancy, particularly when these drugs are given for inflammatory bowel disease rather than for rheumatic conditions, a study found.